OTOLOGIC PHARMACEUTICS
Otologic Pharmaceutics, Inc. is a company committed to developing treatments for acute hearing loss to reduce the development of permanent hearing disorders. OPI’s lead program HPN1010, an oral medication to treat acute hearing loss, will enter clinical trials in 2014. Initial research focuses on Noise Induced Hearing Loss. We will continue to work to expand the applicability of HPN1010 to treat hearing loss from other causes, such as Cisplatin Induced Hearing loss.
OTOLOGIC PHARMACEUTICS
Social Links:
Industry:
Biotechnology Information Technology
Founded:
2009-01-01
Address:
Oklahoma City, Oklahoma, United States
Country:
United States
Website Url:
http://www.otologicpharmaceutics.com
Total Employee:
1+
Status:
Active
Contact:
(405)319-8165
Email Addresses:
[email protected]
Total Funding:
4.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx DigiCert SSL CloudFront Google Adsense AdBlock Acceptable Ads Google Adsense For Domains Thawte SSL
Similar Organizations
![]()
Adgero Biopharmaceuticals
Adgero Biopharmaceuticals, Inc. is a privately-held biopharmaceutical company focused on building a robust pipeline
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
![]()
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
![]()
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
![]()
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Current Employees Featured
![]()
![]()
![]()
![]()
![]()
![]()
Founder
![]()
![]()
![]()
Investors List
![]()
Accele Venture Partners
Accele Venture Partners investment in Series A - Otologic Pharmaceutics
![]()
Oklahoma Medical Research Foundation
Oklahoma Medical Research Foundation investment in Series A - Otologic Pharmaceutics
![]()
i2E
i2E investment in Series A - Otologic Pharmaceutics
Official Site Inspections
http://www.otologicpharmaceutics.com
- Host name: 104.247.81.99
- IP address: 104.247.81.99
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
